Posts

Artificial intelligence unravels mysteries of polycrystalline materials

Artificial intelligence unravels mysteries of polycryst...

Dec 19, 2023

Researchers at Nagoya University in Japan have used artificial intelligence to d...

FDA Places CARsgen Therapeutics’ CAR-T Cell Therapies on Clinical Hold, Impacts Global Expansion Plans

FDA Places CARsgen Therapeutics’ CAR-T Cell Therapies o...

Dec 18, 2023

CARsgen Therapeutics, a Chinese biotech company, is facing a significant setback...

BMJ Investigation Shines Light on Semaglutide U.K. Marketing

BMJ Investigation Shines Light on Semaglutide U.K. Mark...

Dec 18, 2023

A probe conducted by the British Medical Journal (BMJ) has provided insight into...

CymaBay seeks FDA approval for primary biliary cholangitis therapy

CymaBay seeks FDA approval for primary biliary cholangi...

Dec 18, 2023

CymaBay Therapeutics has filed a new drug application (NDA) with the FDA seeking...

EMA CHMP recommends Takeda’s Hyqvia for CIDP treatment

EMA CHMP recommends Takeda’s Hyqvia for CIDP treatment

Dec 18, 2023

The EMA CHMP recommended granting approval for Takeda’s Hyqvia for chronic infla...

FDA backs Astellas-Pfizer’s Padcev with Keytruda for urothelial cancer

FDA backs Astellas-Pfizer’s Padcev with Keytruda for ur...

Dec 18, 2023

The US FDA approved Astellas Pharma-Pfizer’s Padcev plus Merck’s (MSD) Keytruda ...

Pivotal bioVenture raises the stakes in biotech and pharmaceutical support

Pivotal bioVenture raises the stakes in biotech and pha...

Dec 18, 2023

The latest $389m pledge follows an initial investment of $300m in 2017 that was ...

Magazine: Advancing islet transplantation for type 1 diabetes

Magazine: Advancing islet transplantation for type 1 di...

Dec 18, 2023

In this issue: Diabetes researchers oppose the regulation of islet transplantati...

Illumina to divest Grail after two years of lawsuits

Illumina to divest Grail after two years of lawsuits

Dec 18, 2023

Illumina aims to finalise the terms of this divestiture by the end of the second...

Novo Nordisk Foundation sets up airborne infection vaccine initiative

Novo Nordisk Foundation sets up airborne infection vacc...

Dec 18, 2023

The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop v...

Vertex secures CHMP nod for Casgevy approval in Europe

Vertex secures CHMP nod for Casgevy approval in Europe

Dec 18, 2023

Following US and UK approvals, the EMA’s CHMP has recommended conditional approv...

Biocytogen and Ona enter cancer ADC development deal

Biocytogen and Ona enter cancer ADC development deal

Dec 18, 2023

Biocytogen Pharmaceuticals and Ona Therapeutics signed an antibody agreement to ...

Novo Nordisk Foundation’s $260M Initiative Targets Enhanced Respiratory Vaccines

Novo Nordisk Foundation’s $260M Initiative Targets Enha...

Dec 18, 2023

In a major move, the Novo Nordisk Foundation is allocating $260 million to pione...

Checkpoint Therapeutics Faces FDA Setback, but Optimism Persists for Skin Cancer Therapy

Checkpoint Therapeutics Faces FDA Setback, but Optimism...

Dec 18, 2023

Checkpoint Therapeutics, headquartered in Waltham, Massachusetts, recently encou...

Pharvaris’ hereditary angioedema medication reduces attacks in the wake of the FDA hold

Pharvaris’ hereditary angioedema medication reduces att...

Dec 18, 2023

Pharvaris has reported a significant breakthrough in the treatment of hereditary...

Unveiling Weight Regain Trends in Eli Lilly’s Zepbound Study

Unveiling Weight Regain Trends in Eli Lilly’s Zepbound ...

Dec 18, 2023

Patients taking Eli Lilly’s weight loss drug Zepbound faced a substantial weight...